Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Cash from Operations (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Cash from Operations for 12 consecutive years, with 59553000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Operations rose 5.53% year-over-year to 59553000.0; the TTM value through Mar 2026 reached 184007000.0, down 1.87%, while the annual FY2025 figure was 187493000.0, 24.15% down from the prior year.
  • Cash from Operations hit 59553000.0 in Q1 2026 for Wave Life Sciences, down from 33776000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 85522000.0 in Q1 2023 and bottomed at 63039000.0 in Q1 2025.
  • Average Cash from Operations over 5 years is 32075529.41, with a median of 34457000.0 recorded in 2023.
  • Year-over-year, Cash from Operations plummeted 375.47% in 2022 and then skyrocketed 314.49% in 2023.
  • Wave Life Sciences' Cash from Operations stood at 33440000.0 in 2022, then grew by 0.6% to 33239000.0 in 2023, then tumbled by 31.32% to 43648000.0 in 2024, then grew by 22.62% to 33776000.0 in 2025, then plummeted by 76.32% to 59553000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 59553000.0, 33776000.0, and 44666000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.